Oshitani, N.
70  Ergebnisse:
Personensuche X
?
1

Tranilast, an antifibrotic agent and COVID-19-induced pulmo..:

Oshitani, N ; Watanabe, K ; Sakuma, T..
QJM: An International Journal of Medicine.  115 (2022)  4 - p. 249-250 , 2022
 
?
2

The Traditional Japanese Medicine Rikkunshito Promotes Gast..:

Tominaga, K. ; Kido, T. ; Ochi, M....
Evidence-Based Complementary and Alternative Medicine.  2011 (2011)  1 - p. , 2011
 
?
3

Increased numbers of immature plasma cells in peripheral bl..:

Hosomi, S ; Oshitani, N ; Kamata, N...
Clinical and Experimental Immunology.  163 (2010)  2 - p. 215-224 , 2010
 
?
4

Multifunctional effects of anticomplementary agent K-76 on ..:

KITANO, A ; MATSUMOTO, T ; NAKAMURA, S...
Clinical and Experimental Immunology.  94 (2008)  2 - p. 348-353 , 2008
 
?
 
?
 
?
 
?
10

Interactions between the grading of gastric atrophy associa..:

KADOUCHI, K. ; TOMINAGA, K. ; OCHI, M....
Alimentary Pharmacology & Therapeutics.  24 (2006)  s4 - p. 49-57 , 2006
 
?
11

Efficacy and endoscopic prediction of cytapheresis therapy ..:

WATANABE, K. ; OSHITANI, N. ; KAMATA, N....
Alimentary Pharmacology & Therapeutics.  24 (2006)  s4 - p. 147-152 , 2006
 
?
12

Significance of activated mast cells in submucosa and muscu..:

OSHITANI, N. ; KAMATA, N. ; INAGAWA, M....
Alimentary Pharmacology & Therapeutics.  24 (2006)  s4 - p. 1-7 , 2006
 
?
13

Augmented expression of secondary lymphoid tissue chemokine..:

Kawashima, D ; Oshitani, N ; Jinno, Y...
Journal of Clinical Pathology.  58 (2005)  10 - p. 1057-1063 , 2005
 
?
14

Famotidine vs. omeprazole: a prospective randomized multice..:

Fujiwara, Y. ; Higuchi, K. ; Nebiki, H....
Alimentary Pharmacology & Therapeutics.  21 (2005)  s2 - p. 10-18 , 2005
 
?
15

Prevalence of symptomatic gastro‐oesophageal reflux disease..:

Yamamori, K. ; Fujiwara, Y. ; Shiba, M....
Alimentary Pharmacology & Therapeutics.  20 (2004)  s1 - p. 107-111 , 2004
 
1-15